FR

Institut Gustave Roussy

Erasmus+Horizon Europe
gustaveroussy.frCompare
30
Projects
7
Coordinated
23
As Partner
€3,321,338
Total Budget

Budget Range

Min
€1,959
Average
€110,711
Max
€1,486,014

Country Network

Partnered with organisations in 5 countries

Role Distribution

Sector Distribution

Budget by Sector (€)

Projects (30)

P

Multi-stakeholder Education Alliance to Accelerate Drug Development for Children and Adolescent with Cancer (ALADDIN)

Erasmus+ Alliances101056190
€1,486,014
P

Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome

HORIZON.2.1101213916
€136,063
P

An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring

Health101096329
€114,320
P

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Health101096362
€106,073
P

Treating Liver Metastasis

HORIZON.1.1101118936
€101,804
P

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

Health101103746
€99,841
C

OPTIMAL METHODS TO CHARACTERIZE ADC RESISTANCE IN SOLID TUMORS AND IDENTIFY CLINICALLY USEFUL BIOMARKERS

Health101156771
€99,415
P

Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy

Health101136835
€96,510
P

Data-driven cancer genome interpretation for personalised cancer treatment

Health101057509
€95,843
P

Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients

Health101156800
€94,986
P

Real-time biomarker detection systems for rapid medical decision-making in cancer and cardiac diseases

Health101137466
€83,702
P

THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER

Health101057482
€72,350
P

A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

Health101137028
€72,324
C

Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.

Health101095604
€70,161
P

A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

Health101104469
€68,231
P

Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.

Health101214413
€60,039
P

Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

Health101104684
€59,988
P

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

HORIZON.2.1101136549
€59,077
C

First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

Health101104801
€55,777
P

Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management

HORIZON.1.2101227105
€46,975
P

Specific Conjugation of Antibodies to Lipid Photo-peroxidised cancer tissues for their immunogenic ELimination

HORIZON.3.1101185509
€45,543
P

FCAECC Fellowship programme for talented researchers in cancer

MSCA (Marie Skłodowska-Curie)101081298
€42,984
P

Training network for tracking and controlling therapeutic immune cells in cancer

MSCA (Marie Skłodowska-Curie)101168810
€41,306
C

Microbiota-controlled trafficking of immunosuppressive intestinal T cells into cancer

HORIZON.1.1101142062
€24,878
P

Cancer cell plasticity on targeted therapy

HORIZON.1.1101044047
€20,000
P

Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor

HORIZON.3.1101058349
€17,982
P

VHIO International postDoctoral programme for translAtional research

MSCA (Marie Skłodowska-Curie)101179122
€17,194
C

Clonal hematopoiesis in cancer

HORIZON.1.1101221800
€15,000
C

Targeting SWI/SNF-related chromatin remodelling defects in solid tumours

HORIZON.1.1101077864
€14,999
C

ECM and TFEB interplay: from building multidisciplinary devices to unravelling the missing link in cancer

MSCA (Marie Skłodowska-Curie)101110755
€1,959

Partner Network

Organisations with shared project history

Suggested Partners

Based on overlapping networks, sectors, and cross-border potential